1. Home
  2. VIPS vs CYTK Comparison

VIPS vs CYTK Comparison

Compare VIPS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$20.19

Market Cap

9.1B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.32

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
CYTK
Founded
2008
1997
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.0B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
VIPS
CYTK
Price
$20.19
$60.32
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$19.83
$77.87
AVG Volume (30 Days)
2.8M
1.8M
Earning Date
11-20-2025
11-05-2025
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
1.94
N/A
Revenue
$14,983,370,343.00
$87,211,000.00
Revenue This Year
$1.00
$361.33
Revenue Next Year
$2.40
$65.14
P/E Ratio
$10.40
N/A
Revenue Growth
N/A
2609.26
52 Week Low
$12.14
$29.31
52 Week High
$21.08
$69.33

Technical Indicators

Market Signals
Indicator
VIPS
CYTK
Relative Strength Index (RSI) 59.72 41.98
Support Level $19.50 $63.50
Resistance Level $20.49 $67.26
Average True Range (ATR) 0.65 2.79
MACD 0.05 -0.89
Stochastic Oscillator 88.77 4.57

Price Performance

Historical Comparison
VIPS
CYTK

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: